Monoclonal antibodies (MAbs) specific for the rabies virus nucleoprotein (N protein) and non-structural (NS) protein of the nucleocapsid were introduced into adherent cells (fibroblasts and neuroblastoma) by the scrape-loading technique, After the cells had reattached to the substrate, they were infected with rabies virus. Inhibition of infection was monitored by measuring the intracytoplasmic viral nucleocapsid accumulation with an enzyme immunoassay using anti-N protein rabbit serum and by measuring the release of infectious virus with the plaquing system. Seventeen MAbs defining the three independent antigenic sites on the N protein were able to decrease nucleocapsid accumulation and the release of infectious virus. The MAbs describing the two antigenic sites on NS protein also had an antiviral effect on ERA virus. When an anti-N MAb (0.5 ng per cell) was introduced into CVS-infected cells, virus inhibition was complete if the anti-N MAb was introduced between 0 and 5 h post-infection and ineffective beyond 9 h post-infection. The inhibition was dosedependent. The MAbs could block virus multiplication either by 'neutralizing' newly translated N and NS proteins or by impairing the initial transcription of the genome.
INTRODUCTION
Rabies virus, a rhabdovirus of the Lyssavirus genus contains five proteins. Two proteins, the glycoprotein and the matrix protein, are membrane-associated whereas the remaining three, the nucleoprotein (N), the non-structural protein (NS) and the polymerase (L) are bound to the virion RNA of negative polarity and constitute the helically coiled nucleocapsid. The rabies virus replication strategy is similar to that of other negative-strand RNA viruses. The virion RNA is transcribed into five monocistronic mRNAs by virus transcriptase; these mRNAs are then translated, forming the viral proteins. By analogy with vesicular stomatitis virus (VSV), the prototype of the family Rhabdoviridae, it is assumed that a full-length positive strand of RNA is produced and assembled into nucleocapsids and serves as template for production of negative strand genomic progeny RNA. Rabies virus is a highly neurotropic virus which replicates poorly in the striated muscle cells near the site of inoculation (Murphy et al., 1973; Charlton & Casey, 1979) . Unless it has been inactivated by natural or induced host defence mechanisms, the virus enters the sensory nerves exposed in neuromuscular spindles or in motor nerve endplates (Harrison & Murphy, 1978) . The virus then spreads along the peripheral nerves up to the spinal ganglia and the spinal cord before reaching the brain. After its entrance into the nervous system, rabies virus is considered to be invulnerable to the immune response induced by vaccination, because the blood-brain barrier restricts the passage into the nervous system of immune cells and macromolecules such as neutralizing antibodies. The virus might also escape the immune response because of the absence of accessible viral targets since nearly all viruses bud upon endoplasmic membranes of neurons which are not destroyed by the rabies infection (Murphy, 1977) and since the virus seems to pass from one cell to another across cell junctions including synaptic junctions (Charlton & Casey, 1979) .
A possible strategy to stop rabies virus multiplication might be to introduce into the cells some antiviral substance. Monoclonal and polyclonal antibodies directed against the nucleocapsid of 0000-7889 © 1987 SGM VSV were found to be efficient in blocking VSV multiplication; polyclonal antiserum directed against VSV ribonucleoprotein and N-or NS-monospecific antisera inhibit VSV transcription in a cell-free transcription system (Caroll & Wagner, 1978; Harmon & Summers, 1982) as well as N-specific monoclonal antibodies (MAbs) (De et al., 1982; Arnheiter et al., 1984) . N-and NSmonospecific sera and polyclonal anti-N serum can also inhibit replication in a cell-free replication system (Hill & Summers, 1982; Arnheiter et al., 1985) . Furthermore, microinjected N-specific MAbs decrease the release of infectious VSV (Arnheiter et al., 1984) .
MAbs specific to the N and NS proteins of rabies virus have been produced (Wiktor & Koprowski, t978; Libeau & Lafon, 1983 ) and used to define the topography of the antigenic sites on these nucleocapsid proteins (Lafon & Wiktor, 1985) . On the basis of competitive assays using 31 N-or NS-specific MAbs, three antigenic sites on the N and two on the NS proteins were operationally defined. By chemical and enzymic cleavage the two sites of the NS protein and two of the three antigenic sites of the N protein were located (Dietzschold et al., 1987b) .
In order to investigate the capacity of N-and NS-specific MAbs to act as antiviral agents, we tested their ability to block the multiplication of rabies virus in cell culture. The MAbs were introduced into the cells by means of the 'scrape-loading' technique (McNeil et al., 1984) . This technique allows the loading of macromolecules into the cytoplasm of cells adherent to tissue culture dishes. In this cell culture model, the antiviral effect of MAbs describing different antigenic sites on the N and NS proteins were tested against several rabies virus strains.
METHODS
Cells. BSR cells (Sato et al., 1977) a variant line of BHK-21 cells and clone C 1300 mouse neuroblastoma cells (Neuro-2a) (MacMorris & Ruddle, 1974) were propagated in Eagle's MEM supplemented with tryptose phosphate broth and 8 ~ foetal calf serum (FCS) (MEM 8 ~). Human neuroblastoma cells IMR32 (Tumilowicz et al., 1970) were grown in FI0 medium supplemented with 10~ foetal calf serum.
Viruses. Clone-purified challenge virus standard CVS-11 (Kissling, 1958) and ERA (Connaught Laboratories, Ontario, Canada) were propagated in BHK-21 cell monolayers as described (Wiktor, 1973) . A street rabies virus isolated from a vampire bat in Brazil was adapted to cell culture by two passages on Neuro-2a cells and propagated in BHK-21 cells. A strain of the rabies-related Mokola virus (Mokola 5) isolated from a dog in Zimbabwe (Wiktor et al., 1984) was propagated in BHK-21 cells.
MAbs. Ascitic fluids of murine MAbs specific for rabies virus nucleocapsid proteins N and NS were obtained from pristane-primed BALB/c mice and precipitated with ammonium sulphate. The concentration of protein was estimated using the method of BramhaU et al. (1969) . MAb isotypes were determined by enzyme immunoassay using specific anti-lgG subtype sera (Nordic Immunological Laboratories, Tilburg, The Netherlands). For labelling with fluorescein isothiocyanate (F1TC), MAb PVA-3 was dialysed against a carbonate buffer pH 9 and conjugated with FITC in the proportion of 1 mg FITC to 100 mg of protein as described (Atanasiu et al., 1974) . The unconjugated FITC was removed by chromatography on a Sephadex G-50 column.
Scrape-loading. Glass Petri dishes (diam. 90 mm) were seeded with 6 x 106 cells. After 18 h, confluent cells were washed once with 5 ml of MEM without serum and well drained. MAb diluted in MEM without serum to a final volume of 600 itl was poured onto the ceils. Cells were scraped off with a rubber policeman (Costar 3010), washed in 10 ml ice-cold MEM 8~ and centrifuged at 100 g. After a second wash in MEM 8~, the scrape-loaded cells were distributed into the wells of tissue culture plates. Cells may also be scrape-loaded from plastic dishes such as six-well microtitre plates (Falcon 3046), each well having been seeded with 106 cells.
Cell infection. When cells were infected before the MAb incorporation, the virus was left in contact with cell monolayers (1 to 5 p.f.u./cell) at 4 °C for 90 rain. The inoculum was removed, the cells were washed with MEM without serum and then incubated at 37 °C with 10 ml of MEM 8 ~ for various times before the scrape-loading. When cells were infected after the introduction of MAb, infection was performed as soon as cells resumed their fibroblastic shape (5 or 8 h after plating). Medium was removed, cells were washed with medium without serum and the viral inoculum was left in contact with the cells for 1 h at 35 °C. 
Detection of virus antigen by EIA. Infected MAb scrape-loaded cells plated into 96-well tissue culture plates
(30 000 cells per well) were washed and fixed with 80~ acetone. Non-specific binding was avoided by blocking with PBS plus 10~o goat serum. Rabies virus nucleocapsid antigen accumulated in the cytoplasm was detected with a rabbit anti-nucleocapsid serum (dilution l :10000) and with a biotinylated goat anti-rabbit serum plus an avidin-peroxidase reagent (PK-4001 ; Vector Laboratories). Colour detection was as described above.
Immunofluoresence. MAb introduced into the cells was detected after acetone fixation with a fluoresceinconjugated anti-mouse serum (Diagnostics Pasteur, France). Rabies virus nucleocapsid antigen in the infected cells was detected with a fluorescein conjugated anti-rabies virus nucleocapsid serum (Diagnostics Pasteur). Detection of Mokola virus nucleocapsid antigen was performed with an anti-Mokola virus MAb (M30) and an fluorescein-conjugated anti-mouse serum (Diagnostics Pasteur).
Virus production. Titres of infectious virus produced by MAb scrape-loaded and mock scrape-loaded cells (106 cells per well) were estimated by plaquing on CER cells under agarose (Wiktor & Koprowski, 1980; Lafon et al., 1983) . Titres were expressed in p.f.u./ml. Culture medium from six-well plates was collected at 1, 2, 3 or 5 days after infection. At each harvest monolayers were thoroughly washed with MEM 8~ and refed with 2 ml of medium.
Flow cytometry analysis.
To remove large aggregates, cells were filtered immediately after scrape-loading, on a coarse mesh nylon filter. They were diluted to a concentration of 3 x 106 cells/ml in MEM 2~ FCS which had been passed through a 0.22 nm filter to remove autofluorescent serum particles. Viability measurements and estimates of loaded fluorescent MAb were performed in non-sterile conditions. For cell sorting, the fluorograph was sterilized by treatment with PBS containing Ca 2+ and Mg 2÷, filtered through a 0-22 nm filter. Flow cytometry analyses were performed on a Ortho-Diagnostics system 50-HH coupled to a MP-2150 computer. For ethidium bromide exclusion analysis cells were incubated with ethidium bromide solution for 10 min before analysis.
RESULTS

Scrape-loading of MAbs into fibroblastic cells
MAbs specific for the nucleocapsid were introduced into fibroblasts by scraping attached cells from the culture dish with a rubber policeman and resuspending them in ice-cold medium. Either fluorescent or non-fluorescent MAbs were introduced by this method. The viability of scrape-loaded BHK-21 cells was estimated by flow cytometry. Cells loaded with fluorescent anti-N protein MAb (PVA-3) were incubated with ethidium bromide which stains the nuclei of dead cells only. Between 45 and 55~ of BHK-21 fibroblasts were found alive 1 h after scrapeloading (Fig. 1) . These cells regained their fibroblastic shape usually 5 to 8 h after plating on plastic culture plates. Twenty-four h after loading, more than 90 ~ of the viable cells were found to be fluorescent by u.v. microscopy analysis. The uniform fluorescent staining of MAb scrapeloaded cells, as shown in Fig. 2 , suggested that loaded MAb was not trapped in certain cellular compartments but was rather widespread in the cytoplasm. MAbs were also efficiently loaded with this technique into other cell lines such as HEp-2, CER and L-929. 
Scrape-loading of MAbs into neuroblastoma cells
Poorly adherent cells such as Neuro-2a (murine origin) or IMR32 (human origin) were not efficiently loaded with MAb (Fig. 1) . Twenty-four h after loading, only 4 0~ of Neuro-2a were found to be fluorescent by u.v. microscopy analysis. However, the proportion of fluorescent Neuro-2a cells rose to 80~ when plastic culture dishes were pretreated with gelatin which increases cell attachment. Plastic dishes were treated for 3 h at 37 °C with 1 ~o gelatin in distilled water. Cells were then seeded in the treated dishes and scrape-loaded 18 h later.
MAb and cell association
The amount of murine MAb present in the cells was quantified by EIA with a horse antimouse serum, at various times after the scrape-loading. As shown in Fig. 3 , the amount of MAb associated with the cells was a function of the quantity used for loading, up to 3 mg. Above 3 mg the amount of MAb associated with cells began to reach saturation level. The MAb-cell association was very stable for the first 48 h. Cellular clearance of MAb started after 72 h (Fig. 3 ) especially when less than 3 mg was used for loading. Antibody and cell association was no longer measurable after 96 h since at that time the cells began to come off the plates.
The rate of MAb disappearance from the cells seemed to be independent of the isotype, IgG 1, IgG2a or IgG2b. In each experiment the amount of MAb available to the cell was calculated. For example, in the case of the most often tested anti-N protein MAb (PVA-3), 100 ~tl of purified antibody (30 mg/ml) was used for loading 6 × 106 cells; therefore 0.5 ng could be incorporated by a cell. However, the amount of MAb introduced per cell was not precisely measured.
Inhibition of virus multiplication by anti-N MAb ( PVA-3) introduced before infection
BSR cells were scrape-loaded with various amounts ofunlabelled anti-N MAb (PVA-3). After the cells regained their fibroblastic shape, they were used to titrate a CVS stock. The kinetics of rabies virus nucleocapsid appearance was measured by EIA using an anti-nucleocapsid rabbit serum 1, 2 and 3 days after infection. The ability of the anti-N MAb-loaded cells to produce virus was also decreased (see Fig. 5 ). The virus yield was compared in four different cell populations. Cells were either loaded with normal ascitic fluid or with fluorescent anti-N MAb (PVA-3) and sorted with a cytometer or not sorted. Fluorescent cells were sorted into two populations corresponding to 'high' or 'low' fluorescing cells. One and 2 days after the scrape-loading virus production was decreased by a factor of 100 in the two sorted populations when compared to the mock-loaded population (see Fig. 5 ). Three days after scraping, the 'low' fluorescent population produced slightly more infectious virus particles than the 'high fluorescence' population. A greater virus production by ceils that incorporated fewer MAb molecules could be correlated with the beginning of the cellular MAb clearance when less MAb was loaded as observed in Fig. 3 .
The non-sorted MAb-loaded cells produced at any time more virus than the sorted cells. This increase could correspond to a sub-population of non-loaded cells in which virus multiplication was not inhibited.
Specificity of anti-N MAb inhibitory effect
Because the effect of normal ascitic fluid was unknown the specificity of the inhibitory effect of MAbs on virus growth was tested with rabies virus strains that are not recognized by these MAbs. As shown by indirect immunofluorescent staining, some rabies virus strains lack some nucleocapsid epitopes (Wiktor et al., 1980) . For example, the epitopes corresponding to the anti-N MAbs 802-2, 377-7 and 422-2 were absent from the N protein of a vampire bat strain from Brazil (see Table 1 ). Conversely, the epitopes corresponding to the antibodies 802-2 and 377-7 are present on the CVS strain and the epitope corresponding to the MAb 422-2 is present solely on rabies-related viruses such as Mokola virus (see Table 1 ). This range of inhibitory effects showed that inhibition was strictly MAb-specific and depended on the MAb binding to the corresponding target protein. Seventeen anti-N MAbs describing the three antigenic sites on the N protein were tested at equal protein concentration for their ability to block virus multiplication. The tested MAbs were 377-7 and 802-2 from site I, 808-2, 715-3,803-6, 806-1,209-1 and 229-1 from site II and 590-2, 805-3,237-3, 818-1,502-2, 515-3, PVA-3, 239-1 and 389-1 from site III. All of them were found to have an antiviral effect against ERA or CVS virus growth whichever antigenic site they describe or whichever isotype they possess (data not shown),
. Inhibition of infection by fixed and street rabies virus and rabies-related viruses after incorporation of anti-N MAb or anti-NS MAbs describing distinct antigenic sites
Inhibition of virus multiplication by anti-NS MAb introduced before infection
The antiviral effect of two anti-NS MAbs (701-5 and 721-2) locating distinct antigenic sites was assayed when the MAbs were loaded into the cells before infection with the fixed rabies virus strain ERA. The nucleocapsid accumulation of the ERA strain was compared 24 h after scraping in cells loaded with 701-1,721-1 or with normal ascitic fluid (Fig. 6 ). Both anti-NS MAbs were able to inhibit ERA virus growth. Production of infectious virus by cell populations loaded with the anti-NS MAbs 701-5 or 721-2 were decreased to the same extent as in cells treated with anti-N MAb (PVA-3) (see Fig. 5 ). Evidence for specific inhibition by anti-NS MAbs 701-5 and 721-2 was shown (see Table 1 ) by the absence of antiviral effect of these MAbs on Mokola virus whose NS protein lacks the corresponding epitopes.
Inhibition of virus multiplication by anti-N MAbs introduced into cells after rabies virus infection
Confluent cells were infected with CVS virus (m.o.i. 1) incubated at 4 °C with the inoculum for 1 h and then transferred to 37 °C, referred to as time 0 of infection. Cells were scrape-loaded either with a constant amount (100 ~tl) of anti-N MAb (PVA-3) (0-5 ng MAb per cell) or with normal ascitic fluid at various times post-infection and then returned to 37 °C. Virus production was monitored by plaquing 24 h after scrape-loading (see Fig. 7 ). Even in control cells a decrease in virus yield was observed when cells were detached from their support during the first 8 h following infection. No infectious virus was found in the supernatant when MAb had been loaded 2 h after infection, representing a 1000-fold drop in virus production. The MAb introduced 5 h after infection still decreased the virus yield by the same factor even if at that time scrape-loaded cells produced a few virus particles. The drop in virus production was still 100-fold if the MAb had been introduced 8 h after infection and antiviral activity was lost when the MAbs were loaded 11 h after infection. M. LAFON AND M. LAFAGE -~6 ....... 
Dose dependence of antiviral efJect by anti-N MAb (PVA-3) &troduced into cells after infection
Cells were scrape-loaded with two amounts of anti-N MAb PVA-3 (0-05 ng and 0.5 ng per cell) or with normal ascitic fluid at various times post-infection. The MAb antiviral effect on the virus infection was monitored by immunofluorescent staining of nucleocapsid (see Fig. 8 ). Both MAb concentrations were efficient when scrape-loading was carried out during the first hour post-infection. With 0.5 ng of anti-N MAb, 50 % of infected cells were obtained when MAb was loaded 8 h after infection. With 10 times less MAb, 50~/o infected cells appeared when the MAb was loaded 3 h post-infection. These data suggest that the antiviral effect of MAbs is dosedependent.
DISCUSSION
A cell culture model was designed to study the effect on rabies virus multiplication of MAbs specific to internal virus proteins. MAbs were introduced into the cells by the scrape-loading technique of McNeil et al. (1984) either before or after infection. The antiviral activity of the MAbs was evaluated by measuring the accumulation of nucleocapsid in the cells and by measuring the production of infectious virus. The scrape-loading technique allows easy introduction into a large proportion of adherent cells of macromolecules such as immunoglobulins, to which cells are normally impermeable. Cells are detached from their substrate in the presence of the macromolecules and resuspended in ice-cold medium. The mechanism whereby MAbs enter the cells has not yet been elucidated. The inclusion of MAbs into cells could be explained either by changes in cell permeability or by the presence of holes temporarily induced by scraping. The diameter of the holes would have to be at least 14.2 nm which is, according to Sarma et al. (1971) the maximal extension of the IgG molecule. BSR fibroblasts were used in most experiments. However, because neurons are the main target of rabies virus, ceils of neuronal origin such as Neuro-2a or IMR32 were also tested. Efficient MAb loading in these poorly adherent cells was possible only after cells had been cultivated on gelatin-coated dishes. It was not until 2 days after loading that clearance of MAb by the cell population was detected. The clearance seemed to depend on the amount of MAb available for loading (Fig. 3) .
In experiments in which the cells were scrape-loaded with MAbs before infection, nucleocapsid accumulation measured 18 h after infection was reduced by 95 ~ (data not shown) and virus production measured 1 or 2 days after infection dropped by a factor of 100 (Fig. 5) . The residual virus production could correspond to the residual non-loaded cells. However, after sorting, the cell population which contained a high concentration of fluorescent MAb ('high fluorescence" cell population) still produced a few infectious particles (see Fig. 5 ). This virus production could be the progeny of putative virus mutants which escaped the antiviral effect of the anti-N MAb by mutation in the corresponding epitope. To test this hypothesis, 55 clones were isolated by plaquing and tested by indirect immunostaining for their reactivity with MAb PVA-3. All of them were still recognized by anti-N MAb PVA-3, suggesting that the residual virus production by 'high fluorescence' cells most likely resulted from a few cells from which the MAb clearance was faster. The MAb leakage could have occurred in the first 5 to 8 h following the sorting period necessary for the cells to attach and regain their original shape.
In experiments in which cells were scrape-loaded with MAbs after infection, those loaded with normal ascitic fluid in the 5 h following infection released less infectious particles than cells loaded with normal ascitic fluid 8 h or more after infection (Fig. 7) .
It seems that early stages of infection were more sensitive to scraping, perhaps because detachment from the substrate induced a higher mortality rate among such cells. The scraping could also disturb the uptake of virus particles and their processing by endocytosis. Even though the scrape-loading itself was damaging to some infected cells, the introduction of MAb into the cells had another significant effect on virus production (Fig. 7) . The antiviral effect of MAb was shown to depend on binding to its target since the growth of Mokola and Brazilian vampire bat viruses was not modified by MAbs that do not bind to their nucleocapsids (Table 1) . The mechanism whereby anti-nucleocapsid antibodies inhibit virus multiplication inside the cells is unknown. The antiviral activity of MAbs could result directly from the binding of antibodies to biologically active regions of the nucleocapsid proteins. If this is the case the position of at least two of these biologically active regions are identified since the epitopes recognized by some MAbs able to inhibit virus infection have been located. On immunoblotting anti-NS MAbs 701-5 and 721-2 exhibit reactivity with a peptide corresponding to amino acid residues 75 to 88 of the NS protein and anti-N MAbs 377-7 and 802-2 recognize a region located between residues 374 and 383 of the N protein (Dietzschold et al., 1987b) . It is noteworthy that these two regions correspond to major immunogenic domains since they are recognized by both B and T cells (Dietzschold et al., 1987b) . However, no evidence is provided for a direct activity of MAbs since those specific for the nucleocapsid proteins could also be active indirectly by steric blocking of the putative active regions of the nucleocapsid. In post-exposure treatment with anti-N MAb we showed that only early MAb loading was efficient. Like many other enveloped viruses, rabies virus is both able to fuse with the plasma membrane and to enter cells by pinocytosis (Iwasaki et al., 1973 , Tsiang et al., 1984 Superti et al., 1984) . Electron microscopical investigations show that fusion of the virus envelope with the plasma or the internal membranes of vesicles occurs in the first 30 rain following infection. As a result the genome-containing nucleocapsid is released into the cytoplasm. Five h later filamentous structures similar to viral nucleocapsids aggregate in the cytoplasm. Simultaneously the first granules can be detected in the cytoplasm of infected cells by using a fluorescent anti-nucleocapsid serum (Iwasaki et al., 1973) . The aggregated filaments probably correspond to newly synthesized nucleocapsids composed of newly translated N, NS and L proteins associated with genome-complementary or genomic RNAs. Therefore anti-N MAbs introduced into cells have two possible targets, (i) N protein associated either with the infectious nucleocapsid released into the cytoplasm after virus entry or with the newly synthesized nucleocapsid and (ii) free newly translated N protein.
In the first case, binding of MAb to the N protein complexed in the nucleocapsid structure could inhibit mRNA or RNA synthesis because it could modify the flexibility of the nucleocapsid complex and hinder the accessibility of the RNA to the transcriptase, as has been proposed for Sendai virus or VSV (Deshpande & Portner, 1984; Arnheiter et al., 1985) .
In the second case, the newly translated proteins could be 'neutralized' by MAbs and withdrawn from the stock of N proteins available for the encapsidation of nascent RNA. With VSV the polymerase is thought to switch from transcription to replication when enough N protein is synthesized to protect the increasing genomic RNA (Blumberg et al., 1981 ; Lazzarini et al., 1981) . The switch to replication would be blocked as long as each translated N protein was bound to anti-N MAbs. When the stock of MAb molecules was saturated some N protein would be free for RNA encapsidation and the replication step would proceed. In our experiments this may have happened when cells were loaded with MAbs at later infection stages since the longer the time between infection and loading, the less effective was the MAb's antiviral activity. In contrast, in early stages of infection when the MAb targets consist of only a few infectious particles, the balance favoured the antibodies and inhibition of infection was complete.
At present, only antibodies directed at the surface glycoprotein of rabies virus are considered to neutralize the virus and to prevent it invading the central nervous system. However, antibodies directed at the nucleocapsid have been detected in serum of vaccinees who received inactivated vaccines (Perrin et al., 1986) . The question arises whether these anti-nucleocapsid antibodies, which are not neutralizing, play a role in the host defence. The present study shows that anti-N and -NS MAbs artificially loaded can inhibit rabies virus infection. Preliminary results also show that antisera raised against synthetic peptides resembling antigenic sites of the N protein are able to kill infected cells in the presence of complement (Dietzschold et al., 1987 a) . Further investigations are necessary to define the precise roles of the anti-nucleocapsid antibodies and of the nucleocapsid in host defence mechanisms.
